Earnings Call · Q2 FY2021·2021-08-03

Q2 21EPS -17.11%·Rev n/aQ1 21EPS -31.94%·Rev n/aQ4 20EPS +1.11%·Rev n/aQ3 20EPS -22.40%·Rev n/a⚠ consensus missing

NEUROCRINE BIOSCIENCES INC NBIX

Todd Tushla — Vice President, Investor Relations

Kevin Gorman — Chief Executive Officer

Matt Abernethy — Chief Financial Officer

Eiry Roberts — Chief Medical Officer

−4.6%1d on move date−4.1% vs SPY3d−8.3%5d−10.8%

Research tier

Behavioral profile computed for 4 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more NBIX calls or request research access.

More NBIX calls Browse calls Request research access